|
1
|
Core LJ, Waterfall JJ and Lis JT: Nascent
RNA sequencing reveals widespread pausing and divergent initiation
at human promoters. Science. 322:1845–1848. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taft RJ, Pang KC, Mercer TR, Dinger M and
Mattick JS: Non-coding RNAs: Regulators of disease. J Pathol.
220:126–139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long noncoding RNA function in cancer. J
Mol Med Berl. 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding, RNA. An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gutschner T, Baas M and Diederichs S:
Noncoding RNA gene silencing through genomic integration of RNA
destabilizing elements using zinc finger nucleases. Genome Res.
21:1944–1954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang B, Arun G, Mao YS, Lazar Z, Hung G,
Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C and Spector DL:
The lncRNA Malat1 is dispensable for mouse development but its
transcription plays a cis-regulatory role in the adult. Cell Rep.
2:111–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eißmann M, Gutschner T, Hämmerle M,
Günther S, Caudron-Herger M, Groß M, Schirmacher P, Rippe K, Braun
T, Zörnig M and Diederichs S: Loss of the abundant nuclear
non-coding RNA MALAT1 is compatible with life and development. RNA
Biol. 9:1076–1087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tani H, Nakamura Y, Ijiri K and Akimitsu
N: Stability of MALAT-1, a nuclear long non-coding RNA in mammalian
cells, varies in various cancer cells. Drug Discov Ther. 4:235–239.
2010.PubMed/NCBI
|
|
10
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perera FP and Vineis P: Cancer. IARC Sci
Publ. 337–362. 2011.PubMed/NCBI
|
|
12
|
Tan HT, Lee YH and Chung MC: Cancer
proteomics. Mass Spectrom Rev. 31:583–605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dillman RO: Cancer immunotherapy. Cancer
Biother Radiopharm. 26:1–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kryger R, Fan L, Wilce PA and Jaquet V:
MALAT-1, a non protein-coding RNA is upregulated in the cerebellum,
hippocampus and brain stem of human alcoholics. Alcohol.
46:629–634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding
Q, Weng H, Shu YJ, Liu TY, Jiang L, et al: MALAT1 promotes the
proliferation and metastasis of gallbladder cancer cells by
activating the ERK/MAPK pathway. Cancer Biol Ther. 15:806–814.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie
P, Zhou G and Li G: The role of MALAT1 correlates with HPV in
cervical cancer. Oncol Lett. 7:2135–2141. 2014.PubMed/NCBI
|
|
19
|
Wang J, Wang H, Zhang Y, Zhen N, Zhang L,
Qiao Y, Weng W, Liu X, Ma L, Xiao W, et al: Mutual inhibition
between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced
tumourigenesis in liver cancer. Cell Signal. 26:1048–1059. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weber DG, Johnen G, Casjens S, Bryk O,
Pesch B, Jöckel KH, Kollmeier J and Brüning T: Evaluation of long
noncoding RNA MALAT1 as a candidate blood-based biomarker for the
diagnosis of non-small cell lung cancer. BMC Res Notes. 6:5182013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rajaram V, Knezevich S, Bove KE, Perry A
and Pfeifer JD: DNA sequence of the translocation breakpoints in
undifferentiated embryonal sarcoma arising in mesenchymal hamartoma
of the liver harboring the t(11;19)(q11;q13.4) translocation. Genes
Chromosomes Cancer. 46:508–513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyagawa R, Tano K, Mizuno R, Nakamura Y,
Ijiri K, Rakwal R, Shibato J, Masuo Y, Mayeda A, Hirose T and
Akimitsu N: Identification of cis- and trans-acting factors
involved in the localization of MALAT-1 noncoding RNA to nuclear
speckles. RNA. 18:738–751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hutchinson JN, Ensminger AW, Clemson CM,
Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts
identifies two linked noncoding RNAs associated with SC35 splicing
domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakagawa S, Ip JY, Shioi G, Tripathi V,
Zong X, Hirose T and Prasanth KV: Malat1 is not an essential
component of nuclear speckles in mice. RNA. 18:1487–1499. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Spector DL and Lamond AI: Nuclear
speckles. Cold Spring Harb Perspect Biol. 3:a0006462011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and
Prasanth KV: Long noncoding RNA MALAT1 controls cell cycle
progression by regulating the expression of oncogenic transcription
factor B-MYB. PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu C, Yang M, Tian J, Wang X and Li Z:
MALAT-1: A long non-coding RNA and its important 3′ end functional
motif in colorectal cancer metastasis. Int J Oncol. 39:169–175.
2011.PubMed/NCBI
|
|
32
|
Özgür E, Mert U, Isin M, Okutan M, Dalay N
and Gezer U: Differential expression of long non-coding RNAs during
genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clin
Exp Med. 13:119–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marzluff WF: Novel 3′ ends that support
translation. Genes Dev. 26:2457–2460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wilusz JE, Freier SM and Spector DL: 3′
end processing of a long nuclear-retained noncoding RNA yields a
tRNA-like cytoplasmic RNA. Cell. 135:919–932. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tollervey JR, Curk T, Rogelj B, Briese M,
Cereda M, Kayikci M, Hortobágyi T, Nishimura AL, Župunski V, et al:
Characterising the RNA targets and position-dependent splicing
regulation by TDP-43. Nat Neurosci. 14:452–458. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sowalsky AG, Xia Z, Wang L, Zhao H, Chen
S, Bubley GJ, Balk SP and Li W: Whole transcriptome sequencing
reveals extensive unspliced mRNA in metastatic castration-resistant
prostate cancer. Mol Cancer Res. 13:98–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tee AE, Ling D, Nelson C, Atmadibrata B,
Dinger ME, Xu N, Mizukami T, Liu PY, Liu B, Cheung B, et al: The
histone demethylase JMJD1A induces cell migration and invasion by
up-regulating the expression of the long noncoding RNA MALAT1.
Oncotarget. 5:1793–1804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koshimizu TA, Fujiwara Y, Sakai N, Shibata
K and Tsuchiya H: Oxytocin stimulates expression of a noncoding RNA
tumor marker in a human neuroblastoma cell line. Life Sci.
86:455–460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mohamadkhani A: Long noncoding RNAs in
interaction with RNA binding proteins in hepatocellular carcinoma.
Hepat Mon. 14:e187942014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schepens B, Tinton SA, Bruynooghe Y,
Parthoens E, Haegman M, Beyaert R and Cornelis S: A role for hnRNP
C1/C2 and Unr in internal initiation of translation during mitosis.
EMBO J. 26:158–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang F, Yi F, Han X, Du Q and Liang Z:
MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett.
587:3175–3181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guffanti A, Iacono M, Pelucchi P, Kim N,
Soldà G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ,
et al: A transcriptional sketch of a primary human breast cancer by
454 deep sequencing. BMC Genomics. 10:1632009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Guo F, Li Y, Liu Y, Wang J, Li Y and Li G:
Inhibition of metastasis-associated lung adenocarcinoma transcript
1 in CaSki human cervical cancer cells suppresses cell
proliferation and invasion. Acta Biochim Biophys Sin (Shanghai).
42:224–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wei H, Kamat AM, Aldousari S, Ye Y, Huang
M, Dinney CP and Wu X: Genetic variations in the transforming
growth factor beta pathway as predictors of bladder cancer risk.
PLoS One. 7:e517582012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Al-Azayzih A, Gao F, Goc A and Somanath
PR: TGFβ1 induces apoptosis in invasive prostate cancer and bladder
cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated
activation of caspases. Biochem Biophys Res Commun. 427:165–170.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu W, Ji J, Xu Y, Liu Y, Shi L, Liu Y, Lu
X, Zhao Y, Luo F, Wang B, et al: MicroRNA-191, by promoting the EMT
and increasing CSC-like properties, is involved in neoplastic and
metastatic properties of transformed human bronchial epithelial
cells. Mol Carcinog. 54(Suppl 1): E148–E161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Taniguchi M, Fujiwara K, Nakai Y, Ozaki T,
Koshikawa N, Toshio K, Kataba M, Oguni A, Matsuda H, Yoshida Y, et
al: Inhibition of malignant phenotypes of human osteosarcoma cells
by a gene silencer, a pyrrole-imidazole polyamide, which targets an
E-box motif. FEBS Open Bio. 4:328–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li B, Chen P, Qu J, Shi L and Zhuang W, Fu
J, Li J, Zhang X, Sun Y and Zhuang W: Activation of LTBP3 gene by a
long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem
cells from multiple myeloma. J Biol Chem. 289:29365–29375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li L, Feng TT, Lian YY, Zhang GF, Garen A
and Song X: Role of human noncoding RNAs in the control of
tumorigenesis. Proc Natl Acad Sci USA. 106:12956–12961. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang G, Cui Y, Zhang G, Garen A and Song
X: Regulation of proto-oncogene transcription, cell proliferation,
and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
Proc Natl Acad Sci USA. 106:16794–16798. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sephton CF, Cenik C, Kucukural A, Dammer
EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J, et al:
Identification of neuronal RNA targets of TDP-43-containing
ribonucleoprotein complexes. J Biol Chem. 286:1204–1215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rajesh C, Baker DK, Pierce AJ and Pittman
DL: The splicing-factor related protein SFPQ/PSF interacts with
RAD51D and is necessary for homology-directed repair and sister
chromatid cohesion. Nucleic Acids Res. 39:132–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1
promotes tumour growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kuo IY, Wu CC, Chang JM, Huang YL, Lin CH,
Yan JJ, Sheu BS, Lu PJ, Chang WL, Lai WW and Wang YC: Low SOX17
expression is a prognostic factor and drives transcriptional
dysregulation and esophageal cancer progression. Int J Cancer.
135:563–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Abi Khalil C: The emerging role of
epigenetics in cardiovascular disease. Ther Adv Chronic Dis.
5:178–187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Asrih M and Steffens S: Emerging role of
epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc
Pathol. 22:117–125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Park SJ, Kim JG, Son TG, Yi JM, Kim ND,
Yang K and Heo K: The histone demethylase JMJD1A regulates
adrenomedullin-mediated cell proliferation in hepatocellular
carcinoma under hypoxia. Biochem Biophys Res Commun. 434:722–727.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Osawa T, Tsuchida R, Muramatsu M,
Shimamura T, Wang F, Suehiro J, Kanki Y, Wada Y, Yuasa Y, Aburatani
H, et al: Inhibition of histone demethylase JMJD1A improves
anti-angiogenic therapy and reduces tumor-associated macrophages.
Cancer Res. 73:3019–3028. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yang L, Lin C, Liu W, Zhang J, Ohgi KA,
Grinstein JD, Dorrestein PC and Rosenfeld MG: NcRNA- and Pc2
methylation-dependent gene relocation between nuclear structures
mediates gene activation programs. Cell. 147:773–788. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Smith MA, Gesell T, Stadler PF and Mattick
JS: Widespread purifying selection on RNA structure in mammals.
Nucleic Acids Res. 41:8220–8236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hu Q, Kwon YS, Nunez E, Cardamone MD, Hutt
KR, Ohgi KA, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG and
Fu XD: Enhancing nuclear receptor-induced transcription requires
nuclear motor and LSD1-dependent gene networking in interchromatin
granules. Proc Natl Acad Sci USA. 105:19199–19204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wagner EJ and Carpenter PB: Understanding
the language of Lys36 methylation at histone H3. Nat Rev Mol Cell
Biol. 13:115–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Moqadam Akbari F, Lange-Turenhout EA,
Ariës IM, Pieters R and den Boer ML: MiR-125b, miR-100 and miR-99a
co-regulate vincristine resistance in childhood acute lymphoblastic
leukemia. Leuk Res. 37:1315–1321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Sun Y, Wu J, Wu SH, Thakur A, Bollig A,
Huang Y and Liao DJ: Expression profile of microRNAs in c-Myc
induced mouse mammary tumors. Breast Cancer Res Treat. 118:185–196.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Leucci E, Patella F, Waage J, Holmstrøm K,
Lindow M, Porse B, Kauppinen S and Lund AH: MicroRNA-9 targets the
long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep.
3:25352013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Han Y, Liu Y, Zhang H, Wang T, Diao R,
Jiang Z, Gui Y and Cai Z: Hsa-miR-125b suppresses bladder cancer
development by down-regulating oncogene SIRT7 and oncogenic long
non-coding RNA MALAT1. FEBS Lett. 587:3875–3882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bernard D, Prasanth KV, Tripathi V,
Colasse S, Nakamura T, Xuan Z, Zhang MQ, Sedel F, Jourdren L,
Coulpier F, et al: A long nuclear-retained non-coding RNA regulates
synaptogenesis by modulating gene expression. EMBO J. 29:3082–3093.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Isin M, Ozgur E, Cetin G, Erten N, Aktan
M, Gezer U and Dalay N: Investigation of circulating lncRNAs in
B-cell neoplasms. Clin Chim Acta. 431:255–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bonasio R and Shiekhattar R: Regulation of
transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J,
Zhang Y, Chen J, Shen H and Hu Z: A genetic variant in long
non-coding RNA HULC contributes to risk of HBV-related
hepatocellular carcinoma in a Chinese population. PLoS One.
7:e351452012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li G, Zhang H, Wan X, Yang X, Zhu C, Wang
A, He L, Miao R, Chen S and Zhao H: Long noncoding RNA plays a key
role in metastasis and prognosis of hepatocellular carcinoma.
Biomed Res Int. 2014:7805212014.PubMed/NCBI
|
|
74
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Luo JH, Ren B, Keryanov S, Tseng GC, Rao
UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, et al:
Transcriptomic and genomic analysis of human hepatocellular
carcinomas and hepatoblastomas. Hepatology. 44:1012–1024. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Watts R, Ghozlan M, Hughey CC, Johnsen VL,
Shearer J and Hittel DS: Myostatin inhibits proliferation and
insulin-stimulated glucose uptake in mouse liver cells. Biochem
Cell Biol. 92:226–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tian Y, Zhang X, Hao Y, Fang Z and He Y:
Potential roles of abnormally expressed long noncoding RNA UCA1 and
MALAT-1 in metastasis of melanoma. Melanoma Res. 24:335–341. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhao Z, Chen C, Liu Y and Wu C:
17β-Estradiol treatment inhibits breast cell proliferation,
migration and invasion by decreasing MALAT-1 RNA level. Biochem
Biophys Res Commun. 445:388–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Liu SP, Yang JX, Cao DY and Shen K:
Identification of differentially expressed long non-coding RNAs in
human ovarian cancer cells with different metastatic potentials.
Cancer Biol Med. 10:138–141. 2013.PubMed/NCBI
|
|
81
|
Han Y, Liu Y, Nie L, Gui Y and Cai Z:
Inducing cell proliferation inhibition, apoptosis, and motility
reduction by silencing long noncoding ribonucleic acid
metastasis-associated lung adenocarcinoma transcript 1 in
urothelial carcinoma of the bladder. Urology. 81:209e1–209.e7.
2013. View Article : Google Scholar
|
|
82
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
84
|
Zheng HT, Shi DB, Wang YW, Li XX, Xu Y,
Tripathi P, Gu WL, Cai GX and Cai SJ: High expression of lncRNA
MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Int J Clin Exp Pathol. 7:3174–3181. 2014.PubMed/NCBI
|
|
85
|
Chen H, Xin Y, Zhou L, Huang JM, Tao L,
Cheng L and Tian J: Cisplatin and paclitaxel target significant
long noncoding RNAs in laryngeal squamous cell carcinoma. Med
Oncol. 31:2462014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hong SH, Park SJ, Lee S, Cho CS and Cho
MH: Aerosol gene delivery using viral vectors and cationic carriers
for in vivo lung cancer therapy. Expert Opin Drug Deliv.
12:977–991. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Lopez-Ayllon BD, Moncho-Amor V, Abarrategi
A, de Ibañez Cáceres I, Castro-Carpeño J, Belda-Iniesta C, Perona R
and Sastre L: Cancer stem cells and cisplatin-resistant cells
isolated from non-small-lung cancer cell lines constitute related
cell populations. Cancer Med. 3:1099–1111. 2014. View Article : Google Scholar : PubMed/NCBI
|
